Progress against laryngeal cancer in the Netherlands between 1989 and 2010

International Journal of Cancer

Volumn 134, Issue 3, 2014, Pages 674-681

  Van Dijk, Boukje A C ^a,b   Karim Kos, Henrike E ^c   Coebergh, Jan Willem ^c,d   Marres, Henri A M ^e   De Vries, Esther ^c  

^a Department of Registration and Research   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d The Netherlands   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cancer; incidence; larynx; mortality; survival; treatment; trends

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIGLOTTIS CANCER; FEMALE; HUMAN; LARYNX CANCER; LARYNX SQUAMOUS CELL CARCINOMA; LARYNX SURGERY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; TREND STUDY;

EID: 84887994819     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28388     Document Type: Article

References (46)

1. Nederlandse Kankerregistratie. Cijfers over kanker in Nederland. 2012. Available at: www.cijfersoverkanker.nl. Accessed January 28, 2013.
2. Centraal Bureau voor de Statistiek. Kerncijfers bevolking. 2012. Available at: http://statline.cbs.nl/StatWeb/publication/?VW=T&DM= SLNL&PA=37296ned& D1=a&D2=0,10,20,30,40,50,(l-1)-l&HD=130128- 0949&HDR=G1&STB=T. Accessed January 28, 2013.
3. Bosetti C, Garavello W, Levi F, et al. Trends in laryngeal cancer mortality in Europe. Int J Cancer 2006; 119: 673-81.
4. Zigon G, Berrino F, Gatta G, et al. Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study. Ann Oncol 2011; 22: 165-74.
5. Raitiola H, Pukander J, Laippala P,. Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis. Acta Otolaryngol 1999; 119: 847-51.
6. Lee YC, Boffetta P, Sturgis EM, et al. Involuntary smoking and head and neck cancer risk: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2008; 17: 1974-81.
7. Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2009; 18: 541-50.
8. Talamini R, Bosetti C, La VC, et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control 2002; 13: 957-64.
9. La Vecchia C, Zhang ZF, Altieri A,. Alcohol and laryngeal cancer: an update. Eur J Cancer Prev 2008; 17: 116-24.
10. Dikshit RP, Boffetta P, Bouchardy C, et al. Lifestyle habits as prognostic factors in survival of laryngeal and hypopharyngeal cancer: a Multicentric European Study. Int J Cancer 2005; 117: 992-5.
11. Spector JG, Sessions DG, Haughey BH, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 2001; 111: 1079-87.
12. Langendijk JA, Slotman BJ, van der Waal I, et al. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Cancer 2005; 104: 1408-17.
13. Castelijns JA, van den Brekel MW, Hermans R,. Imaging of the larynx. Semin Roentgenol 2000; 35: 31-41.
14. Champion GA, Piccirillo JF,. The impact of computed tomography on pretherapeutic staging in patients with laryngeal cancer: demonstration of the will Rogers' phenomenon. Head Neck 2004; 26: 972-6.
15. Prehn RB, Pasic TR, Harari PM, et al. Influence of computed tomography on pretherapeutic tumor staging in head and neck cancer patients. Otolaryngol Head Neck Surg 1998; 119: 628-33.
16. van den Brekel MW, Castelijns JA,. What the clinician wants to know: surgical perspective and ultrasound for lymph node imaging of the neck. Cancer Imaging 2005; 5: S41-S49.
17. Silver CE, Beitler JJ, Shaha AR, et al. Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 2009; 266: 1333-52.
18. Nederlandse Werkgroep Hoofd Hals Tumoren. Larynxcarcinoom. landelijke richtlijn, versie: 3.0. 2010.
19. Fritz A, Percy C, Jack A, et al. International classification of diseases for oncology. Geneva: World Health Organization, 2000.
20. Hermanek P, Sobin LH, eds. TNM classification of malignant tumours, 4th edn. Berlin: Springer-Verlag, 1987.
21. Hermanek P, Sobin LH, eds. TNM classification of malignant tumours, 4th edn., 2nd revision. Berlin: Springer-Verlag, 1992.
22. Sobin LH, Wittekind C, eds. TNM classification of malignant tumours, 5th edn. New York: Wiley Periodicals, 1997.
23. Sobin LH, Wittekind C, eds. TNM classification of malignant tumours, 6th edn. New York: Wiley Periodicals, 2002.
24. Sobin LH, Gospodarowicz MK, Wittekind C, eds. TNM classification of malignant tumours, 7th edn. New York: Blackwell Publishing Ltd, 2010.
25. van der Sanden GA, Coebergh JW, Schouten LJ, et al. Cancer incidence in the Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry coordinating committee for regional cancer registries. Eur J Cancer 1995; 31A: 1822-9.
26. Schouten LJ, Hoppener P, van den Brandt PA, et al. Completeness of cancer registration in Limburg, the Netherlands. Int J Epidemiol 1993; 22: 369-76.
27. Kim H, Fay M, Feuer E, et al. Permutation tests for Joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-51; correction: 2001;20:655.
28. Dickman PW, Sloggett A, Hills M, et al. Regression models for relative survival. Stat Med 2004; 23: 51-64.
29. Coupland VH, Chapman P, Linklater KM, et al. Trends in the epidemiology of larynx and lung cancer in south-east England, 1985-2004. Br J Cancer 2009; 100: 167-9.
30. Karim-Kos HE, de Vries E, Soerjomataram I, et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44: 1345-89.
31. Makitie A, Pukander J, Raitiola H, et al. Changing trends in the occurrence and subsite distribution of laryngeal cancer in Finland. Eur Arch Otorhinolaryngol 1999; 256: 277-9.
32. Kachuri L, De P, Ellison LF, et al. Cancer incidence, mortality and survival trends in Canada, 1970-2007. Chronic Dis Inj Can 2013; 33: 69-80.
33. van Laar MW, Cruts AAN, Verdurmen JEE, et al. Nationale drug monitor jaarbericht 2007. Utrecht: Trimbos-Instituut, 2008.
34. Feenstra TL, van Genugten ML, Hoogenveen RT, et al. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med 2001; 164: 590-6.
35. Karim-Kos HE, Janssen-Heijnen ML, van Iersel CA, et al. The beginning of the end of the lung cancer epidemic in Dutch women? Int J Cancer 2008; 123: 1472-5.
36. De Stefani E, Boffetta P, Deneo-Pellegrini H, et al. Supraglottic and glottic carcinomas: epidemiologically distinct entities? Int J Cancer 2004; 112: 1065-71.
37. Anonymous Survival of Cancer Patients in Europe: The EUROCARE Study. 2011. Available at: http://www.eurocare.it/Database/tabid/77/Default.aspx. Accessed November 21, 2011.
38. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116: 1-13.
39. Ellis L, Rachet B, Birchall M, et al. Trends and inequalities in laryngeal cancer survival in men and women: England and Wales 1991-2006. Oral Oncol 2012; 48: 284-9.
40. Cosetti M, Yu GP, Schantz SP,. Five-year survival rates and time trends of laryngeal cancer in the US population. Arch Otolaryngol Head Neck Surg 2008; 134: 370-9.
41. Zhang H, Travis LB, Chen R, et al. Impact of radiotherapy on laryngeal cancer survival: a population-based study of 13,808 US patients. Cancer 2012; 118: 1276-87.
42. Severi G, Plesko I, Robertson C, et al. Larynx cancer in Slovakia and the role of anatomical subsites. Oral Oncol 1999; 35: 564-70.
43. Chen AY, Fedewa S, Zhu J,. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007. Arch Otolaryngol Head Neck Surg 2011; 137: 1017-24.
44. Olsen KD,. Reexamining the treatment of advanced laryngeal cancer. Head Neck 2010; 32: 1-7.
45. Wolf GT,. Reexamining the treatment of advanced laryngeal cancer: the VA laryngeal cancer study revisited. Head Neck 2010; 32: 7-14.
46. Forastiere AA,. Larynx preservation and survival trends: should there be concern? Head Neck 2010; 32: 14-17.